Traditional Chinese medicine for relieving postoperative hypomenorrhea of thyroid cancer patients

Abstract

The invention relates to a traditional Chinese medicine for relieving postoperative hypomenorrhea of thyroid cancer patients, which can relieve multiple clinical symptoms of thyroid cancer in post-operation, accelerate postoperative recovery, and improve living quality of patients. The traditional Chinese medicine includes: 10-20 g of ginseng, 15-25 g of Chinese yam, 10-20 parts of astragalus membranaceus, 10-20 g of poria cocos, 10-20 g of atractylodes macrocephala, 10-25 g of donkey-hide gelatin, 10-20 g of rhizoma chuanxiong, 10-20 g of angelica sinensis, 10-20 g of white peony roots, 10-25g of prepared radix rehmanniae, 10-20 g of eucommia ulmoides, 10-20 g of Chinese wolfberries, 25-30 g of glossy privet fruits, 15-25 g of dendrobium, 25-30 g of radix ophiopogonis, 25-30 g of herba ecliptae, 25-30 g of mulberry fruits, 25-30 g of herba leonuri, 10-20 g of radix achyranthis bidentatae, 5-15 g of fructus amomi and 5-15 g of radix bupleuri. The medicines are decocted in water and then a decoction is filtered, and a filtrate is concentrated to 200-300 ml. The traditional Chinese medicine has functions of fortifying spleen to boost Qi, nourishing blood and regulating menstruation,can effectively relieve the clinical symptoms, such as hypomenorrhea, of postoperative thyroid cancer patients, is safe to use and can accelerate postoperative recovery of patients, improve living quality of the patients, and prevent and delay the recurrence and metastasis of the thyroid cancer.

Description

technical field [0001] The invention relates to medicine, in particular to a traditional Chinese medicine for improving postoperative oligomenorrhea in patients with thyroid cancer. Background technique [0002] Thyroid cancer is the most common malignant tumor in the head and neck, accounting for 1% to 2% of systemic malignant tumors. It is more common in women and can be found in any age group. At present, the incidence of thyroid cancer is increasing significantly year by year. Thyroid cancer is divided into papillary adenocarcinoma, follicular carcinoma, anaplastic carcinoma, medullary carcinoma and other types. Among them, papillary carcinoma is the most common clinical, accounting for 50% to 70% of thyroid cancer. Thyroid cancer treatment methods include surgery, radiation therapy, chemotherapy, endocrine therapy and traditional Chinese medicine. Currently "surgery + 131 "I therapy + thyroid hormone suppression" is recognized as the best comprehensive treatment pla...

AI Technical Summary

Problems solved by technology

Although there are a variety of drugs for its treatment, due to various reasons, its use is not satisfactory. Therefore, improvement and innovation in drugs is imperative